• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在马免疫球蛋白生产过程中,通过辛酸沉淀继以最终巴氏杀菌对病毒进行分离和灭活。

Partitioning and inactivation of viruses by the caprylic acid precipitation followed by a terminal pasteurization in the manufacturing process of horse immunoglobulins.

作者信息

Mpandi M, Schmutz P, Legrand E, Duc R, Geinoz J, Henzelin-Nkubana C, Giorgia S, Clerc O, Genoud D, Weber T

机构信息

R & D, Serolab s.a., Chemin de la Vulliette 4, CP 36, 1000 Lausanne 25, Switzerland.

出版信息

Biologicals. 2007 Oct;35(4):335-41. doi: 10.1016/j.biologicals.2007.02.004. Epub 2007 Apr 30.

DOI:10.1016/j.biologicals.2007.02.004
PMID:17470396
Abstract

Caprylic acid (octanoic acid), has been used for over 50 years as a stabilizer of human albumin during pasteurization. In addition caprylic acid is of great interest, by providing the advantage of purifying mammalian immunoglobulins and clearing viruses infectivity in a single step. Exploiting these two properties, we sequentially used the caprylic acid precipitation and the pasteurization to purify horse hyperimmune globulins used in the manufacturing of Sérocytol. To evaluate the effectiveness of the process for the removal/inactivation of viruses, spiking studies were carried out for each dedicated step. Bovine viral diarrhoea virus (BVDV), pseudorabies virus (PRV), encephalomyocarditis virus (EMCV) and minute virus of mice (MVM) were used for the virological validation. Our data show that the treatment with caprylic acid 5% (v/v) can effectively be used as well to purify or to ensure viral safety of immunoglobulins. Caprylic acid precipitation was very efficient in removing and/or inactivating enveloped viruses (PRV, BVDV) and moderately efficient against non-enveloped viruses (MVM, ECMV). However the combination with the pasteurization ensured an efficient protection against both enveloped and non-enveloped viruses. So that viruses surviving to the caprylic acid precipitation will be neutralized by pasteurization. Significant log reduction were achieved > or =9 log(10) for enveloped viruses and 4 log(10) for non-enveloped viruses, providing the evidence of a margin of viral safety achieved by our manufacturing process. Its a simple and non-expensive manufacturing process of immunoglobulins easily validated that we have adapted to a large production scale with a programmable operating system.

摘要

辛酸(正辛酸)在巴氏灭菌过程中作为人白蛋白的稳定剂已使用了50多年。此外,辛酸备受关注,因为它具有一步纯化哺乳动物免疫球蛋白并清除病毒感染性的优势。利用这两个特性,我们依次使用辛酸沉淀和巴氏灭菌法来纯化用于生产赛罗西托尔的马超免疫球蛋白。为了评估该工艺去除/灭活病毒的有效性,对每个专门步骤进行了加标研究。牛病毒性腹泻病毒(BVDV)、伪狂犬病病毒(PRV)、脑心肌炎病毒(EMCV)和小鼠微小病毒(MVM)用于病毒学验证。我们的数据表明,5%(v/v)的辛酸处理也可有效地用于纯化或确保免疫球蛋白的病毒安全性。辛酸沉淀在去除和/或灭活包膜病毒(PRV、BVDV)方面非常有效,对非包膜病毒(MVM、EMCV)的效果中等。然而,与巴氏灭菌相结合可确保对包膜病毒和非包膜病毒都有高效的保护作用。这样,在辛酸沉淀后存活的病毒将被巴氏灭菌中和。包膜病毒的对数减少量显著达到≥9 log₁₀,非包膜病毒为4 log₁₀,这证明了我们的生产工艺实现了病毒安全裕度。这是一种简单且成本不高的免疫球蛋白生产工艺,易于验证,我们已通过可编程操作系统将其应用于大规模生产。

相似文献

1
Partitioning and inactivation of viruses by the caprylic acid precipitation followed by a terminal pasteurization in the manufacturing process of horse immunoglobulins.在马免疫球蛋白生产过程中,通过辛酸沉淀继以最终巴氏杀菌对病毒进行分离和灭活。
Biologicals. 2007 Oct;35(4):335-41. doi: 10.1016/j.biologicals.2007.02.004. Epub 2007 Apr 30.
2
Assessment of viral inactivation during pH 3.3 pepsin digestion and caprylic acid treatment of antivenoms.抗蛇毒血清在pH 3.3胃蛋白酶消化和辛酸处理过程中病毒灭活的评估。
Biologicals. 2007 Oct;35(4):329-34. doi: 10.1016/j.biologicals.2006.11.003. Epub 2007 Mar 23.
3
Virus reduction in the preparation of intravenous immune globulin: in vitro experiments.静脉注射免疫球蛋白制备过程中的病毒去除:体外实验
Transfusion. 1999 Mar;39(3):249-57. doi: 10.1046/j.1537-2995.1999.39399219280.x.
4
Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma.一种高纯度人血浆来源10%液体静脉注射免疫球蛋白制剂的生物安全性
BioDrugs. 2017 Jun;31(3):251-261. doi: 10.1007/s40259-017-0222-9.
5
Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product.新型15纳米过滤液体免疫球蛋白产品Nanogam的病毒安全性
Vox Sang. 2006 Jan;90(1):21-32. doi: 10.1111/j.1423-0410.2005.00710.x.
6
Low pH, caprylate incubation as a second viral inactivation step in the manufacture of albumin. Parametric and validation studies.低pH值、辛酸盐孵育作为白蛋白生产中的第二个病毒灭活步骤。参数研究与验证研究。
Biologicals. 2003 Sep;31(3):213-21. doi: 10.1016/s1045-1056(03)00062-9.
7
Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process.通过科恩分级分离法生产的经pH 4处理的人免疫球蛋白产品的病毒验证
Biologicals. 1998 Dec;26(4):267-76. doi: 10.1006/biol.1998.0148.
8
Viral safety of C1-inhibitor NF.C1抑制剂NF的病毒安全性
Biologicals. 2007 Jun;35(3):173-81. doi: 10.1016/j.biologicals.2006.08.005. Epub 2006 Oct 30.
9
Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.使用溶剂/去污剂处理和巴氏灭菌法灭活静脉注射免疫球蛋白G中的病毒。
Hum Antibodies. 2008;17(3-4):79-84.
10
Inactivation of viruses by pasteurization at 60 °C for 10 h with and without 40% glucose as stabilizer during a new manufacturing process of α2-Macroglobulin from Cohn Fraction IV.在从科恩IV组分生产α2-巨球蛋白的新制造过程中,于60°C下分别在有和没有40%葡萄糖作为稳定剂的情况下进行10小时巴氏杀菌对病毒的灭活作用。
Biologicals. 2017 Mar;46:139-142. doi: 10.1016/j.biologicals.2017.01.009. Epub 2017 Feb 17.

引用本文的文献

1
Modeling virus filtration: Materials, applications, and mechanism.病毒过滤建模:材料、应用及机制
iScience. 2024 Dec 4;28(1):111533. doi: 10.1016/j.isci.2024.111533. eCollection 2025 Jan 17.
2
Understanding virus retention mechanisms on protein a chromatography based on using different wash buffers - Evaluating the possibility for a generic wash buffer toolbox to improve virus clearance capacity.基于使用不同洗涤缓冲液理解蛋白A色谱上的病毒保留机制——评估通用洗涤缓冲液工具箱提高病毒清除能力的可能性。
Biotechnol Notes. 2024 Mar 26;5:50-57. doi: 10.1016/j.biotno.2024.03.001. eCollection 2024.
3
Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland.
回归细胞疗法的摇篮:整合一个世纪的临床研究与基于生物技术的制造,用于瑞士现代组织特异性细胞治疗
Bioengineering (Basel). 2021 Dec 17;8(12):221. doi: 10.3390/bioengineering8120221.
4
Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19.开发和鉴定两种针对 SARS-CoV-2 蛋白的马用制剂,用于治疗 COVID-19 的潜在用途。
Sci Rep. 2021 May 10;11(1):9825. doi: 10.1038/s41598-021-89242-z.
5
Minipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance immunoglobulin supply in developing countries.采用一次性设备对血浆进行辛伐他汀分馏:提高发展中国家免疫球蛋白供应的实用方法。
PLoS Negl Trop Dis. 2015 Feb 26;9(2):e0003501. doi: 10.1371/journal.pntd.0003501. eCollection 2015 Feb.
6
Safety of snake antivenom immunoglobulins: efficacy of viral inactivation in a complete downstream process.蛇抗毒血清免疫球蛋白的安全性:完整下游工艺中病毒灭活的效果。
Biotechnol Prog. 2013 Jul-Aug;29(4):972-9. doi: 10.1002/btpr.1758. Epub 2013 Jun 27.